Blueshift Asset Management’s Edwards Lifesciences EW Stock Holding History

Blueshift Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-4,457	Closed	-$294K	–	406
2024 Q3	$294K	Buy	+4,457	New	+$324K	0.07%	283
2023 Q4	–	Sell	-3,289	Closed	-$228K	–	294
2023 Q3	$228K	Buy	+3,289	New	+$264K	0.13%	231
2023 Q2	–	Sell	-2,567	Closed	-$212K	–	390
2023 Q1	$212K	Buy	+2,567	New	+$202K	0.09%	294
2022 Q4	–	Sell	-5,086	Closed	-$420K	–	437
2022 Q3	$420K	Buy	+5,086	New	+$489K	0.09%	320
2021 Q3	–	Sell	-2,642	Closed	-$274K	–	1081
2021 Q2	$274K	Buy	+2,642	New	+$249K	0.02%	755
2021 Q1	–	Sell	-33,257	Closed	-$3.03M	–	914
2020 Q4	$3.03M	Buy	+33,257	New	+$2.76M	0.36%	65
2019 Q2	–	Sell	-7,176	Closed	-$458K	–	775
2019 Q1	$458K	Sell	7,176 -19,314	-73%	-$1.1M	0.06%	419
2018 Q4	$1.35M	Buy	+26,490	New	+$1.34M	0.25%	94

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Blueshift Asset Management's EW Position: Q4 2024 in Review

Blueshift Asset Management sold out of Edwards Lifesciences (EW) in Q4 2024, closing a stake of 4,457 shares — an estimated $294K sold.

Blueshift Asset Management first reported a position in EW in Q4 2018 and held it in 8 quarters. The position peaked at $3.03M in Q4 2020. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2024.

Blueshift Asset Management reported no remaining Edwards Lifesciences position as of Q4 2024 after selling out during the quarter.
Blueshift Asset Management sold 4,457 Edwards Lifesciences shares in Q4 2024, an estimated $294K.
Blueshift Asset Management first reported a position in Edwards Lifesciences in Q4 2018 and held it in 8 quarters.
Blueshift Asset Management's Edwards Lifesciences position peaked at $3.03M in Q4 2020.
1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2024.

Based on Blueshift Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.